Rex Sealing (543744)
TurnaroundScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹177.95 |
| Market Cap | ₹50.32 Cr |
| P/E Ratio | 28.16 |
| ROCE | 12.91% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -39.13% |
| Debt/Equity | — |
| Sales Growth | -4.85% |
| 52-Week Range | ₹140 — ₹216 |
| Sector | Industrial Products |
Strengths
- Latest quarter profitable: ₹17 Cr sales and ₹1 Cr net profit, implying roughly 5.9% net margin.
- ROCE of 12.91% suggests acceptable capital efficiency if maintained.
- Current price of ₹177.95 is below the 52-week high of ₹216, leaving limited downside if the business stabilises.
- The company is still generating positive net profit, so it is not burning cash or in acute distress.
Concerns
- P/E of 28.16 is expensive for a business with 39.13% profit decline.
- Sales growth is negative at -4.85% and profit growth is sharply negative at -39.13%.
- Piotroski F-Score of 3/9 indicates weak financial health and deteriorating fundamentals.
- Zero dividend yield offers no compensation while waiting for a recovery.
AI Analysis
Looking at Rex Sealing, I am reminded that a small price tag can still be an expensive valuation. At ₹177.95, the market capitalises this packaging company at only ₹50 crore, yet the P/E ratio stands at 28.16. That is a rich multiple for a business whose sales have fallen 4.85% and whose profit has collapsed by 39.13%. Graham would ask: where is the margin of safety? I do not see it. The latest quarter shows ₹17 crore of revenue and ₹1 crore of net profit, which is a small positive, but it does not reverse the annual trend. ROCE of 12.91% is respectable, but if earnings keep falling, that return will deteriorate. The Piotroski F-Score of 3 out of 9 reinforces my caution; the underlying financial health is weak. There is no dividend, so I receive no income while waiting for a recovery. I would normally want a durable moat, pricing power, or a strong balance sheet. In this packaging business, I find none of those from the numbers available. Book value, ROE and promoter holding are not disclosed, so I cannot even complete the basic Graham checklist. At best, this is a possible turnaround candidate; at worst, it is a value trap. I would need several quarters of stable or growing sales, improved margins, and cleaner financials before I could consider investing. Until then, the market is asking me to pay 28 times earnings for declining profit. That is not my idea of value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer